Indira IVF Hospital Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Indira IVF Hospital Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of TBD. The offering comprises a fresh issue component of TBD.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE, BSE exchange.
Indira IVF is a leading chain of fertility clinics in India with over 165 centres and a team of more than 340 IVF specialists across 20+ states. The company provides a wide range of fertility treatments including IVF, IUI, ICSI, cryopreservation of eggs and embryos, laparoscopic and hysteroscopic procedures, male infertility treatments, and genetic testing services. With its large network and advanced medical solutions, Indira IVF supports couples in their journey toward parenthood through comprehensive and specialised fertility care.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium is based on market buzz and online information. It should not be considered as the actual listing price or valuation. Always refer to the RHP and seek advice from a financial expert before making any investment decisions.
- Strong Position in Fertility Services: One of the leading IVF and fertility care providers in India, benefiting from rising awareness and demand for infertility treatments.
- Wide Network of Clinics: Operates multiple centers across cities, improving accessibility and patient reach.
- Specialized Medical Expertise: Focused IVF treatment capabilities with trained doctors and advanced reproductive technologies support high success rates and trust.
- High Treatment Cost Sensitivity: IVF services are expensive, which can limit customer base to specific income segments.
- Regulatory & Ethical Oversight: Healthcare and fertility services are subject to strict regulations and medical guidelines.
- Reputation Dependent Business: Success rates and patient outcomes directly impact brand trust and future demand.
NA
Indira IVF Hospital Limited